In line with our vision, our biotechnologies…
Replace metals: Our biotechnologies allow ‘hydrogenation’ reactions to run under mild conditions (temperature, pressure) and benefit from the exquisite precision of redox biocatalysis.
Decarbonise biocatalysis: We believe that improving implementation of redox biocatalysis will ultimately speed up a switch to bio-based feedstocks, building circular and bio-based economies.
Our pioneering biomanufacturing solutions
bring together the best of biology and chemistry for cleaner, safer, cheaper chemical production, and make use of existing chemical manufacturing infrastructure allowing us to compete on lower barriers-to-entry.
Our evaluation products put you in control
If you are interested to get started with our biocatalytic hydrogenation technologies, why not get in touch?
These products have been demonstrated in continuous flow reactors including the H-cube (ThalesNano) and AM Technology ACR.
Our Bio2Amine products are being showcased for generic APIs such as Paracetamol production. See our 1-pager here, and email for more information.
Technology showcases
Bio2Amine
This heterogenous biocatalyst shows excellent scope, selectivity and productivity for nitro-to-amine conversions. Some of the academic work has been published and our work at HydRegen is aligned with rapid scalability and intensification.
H2BioCat
This technology platform supports NADH-dependent enzymes, providing a 100% atom efficient cofactor recycling system, and allowing intensification of process conditions.
